MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Treatment with Mucuna pruriens Plus Solo Carbidopa Prescription in Patient Reluctant to Initiation of Traditional Levodopa/Carbidopa Medication

    T. Denne (Mission Viejo, USA)

    Objective: To see if treatment with Mucuna pruriens 2 capsules (15% levodopa) TID, plus solo carbidopa prescription 25mg TID in patient reluctant to traditional levodopa/carbidopa management could help…
  • 2025 International Congress

    Opicapone for OFF Motor Fluctuations in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Trials

    A. Fornari Caprara, J. Pitton Rissardo (Camden, USA)

    Objective: To evaluate the efficacy of opicapone 50 mg in reducing OFF time and improving motor function in Parkinson’s disease (PD) patients with motor fluctuations.…
  • 2025 International Congress

    Do Peripheral Inflammatory Markers Predict Impulse Control Disorders in Parkinson’s Disease? Insights from a Retrospective Study

    N. Durmaz Celi̇k, M. Yildiz, S. Ozkan (Eskisehir, Turkey)

    Objective: To evaluate the relationship between hematological inflammatory markers—neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR)—and ICD development in PD patients treated with…
  • 2025 International Congress

    Effect of Antihypertensive Agent Choice on Parkinson’s Disease Progression in Patients with Hypertension

    R. Gologorsky, A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the effect of different classes of antihypertensive medications on Parkinson’s disease progression. Background: Cardiovascular risk factors such as hypertension can worsen Parkinson’s…
  • 2025 International Congress

    Establishing Clinical Education and Patient Support Programs for Continuous Subcutaneous Apomorphine Infusion (CSAI) in the United States

    N. Crouse, C. Happel, M. Grall (Rockville, USA)

    Objective: Establish an educational “Master Class” program to prepare health care providers (HCPs) for CSAI availability in the U.S. and develop educational support for people…
  • 2025 International Congress

    A scoping review of safer mobility behaviour for falls prevention: Implications for people with Parkinson’s disease.

    D. Cheung, J. Wesson, S. Paul, L. Mackenzie, L. Goh, C. Canning, L. Almeida, M. Enright, N. Allen (Camperdown, Australia)

    Objective: To map out the definition and concepts of safer mobility behaviour and how it is applied through assessment and intervention for fall prevention in…
  • 2025 International Congress

    Trihexyphenidyl as a Treatment for Severe Freezing of Gait in Parkinson’s Disease: A Case Report

    J. Ha, M. Ferris (Palo Alto, USA)

    Objective: To present a unique case in which trihexyphenidyl was used as an effective treatment to dramatically reduce freezing of gait (FoG) in a Parkinson’s…
  • 2025 International Congress

    The Effectiveness of Drug-Disease Best Practice Advisory Alerts for Preventing the Administration of Contraindicated Medications in Patients with Parkinsonism

    A. Kundrick, M. Fedorova, B. Sokola, B. Walter (Cleveland, USA)

    Objective: To determine the effectiveness of drug-disease best practice advisory alerts at preventing the administration of contraindicated medications in patients with parkinsonism as a quality…
  • 2025 International Congress

    Impact of Insurance and Risk Factors on DBS Outcomes

    K. Stefanescu, K. Hu, X. Lei, S. Cen, B. Lee, D. Lee, X. Mason (Los Angeles, USA)

    Objective: Assess the effect of insurance type on deep brain stimulation (DBS) outcomes, and identify risk factors for progression to assisted ambulation and dependency (home…
  • 2025 International Congress

    Deep Brain Stimulation for Early-Onset Parkinson’s Disease: A Systematic Review and Meta-Analysis

    K. Acurio-Ortiz, M. Hemeryth-Rengifo, G. Quispe-Villegas, F. Váscones-Román, V. Abuid-Sampelayo, D. Salazar-Flores, C. Quispe-Vicuña, A. Flores-Gavino, B. Avila-Lucas, M. Vilca-Salas, N. Pacheco-Barrios (Lima, Peru)

    Objective: To evaluate clinical outcomes in patients with Early-Onset Parkinson’s Disease (EOPD) treated with deep brain stimulation (DBS) Background: EOPD is defined as Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 360
  • 361
  • 362
  • 363
  • 364
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley